AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02/0.0/0.0/20_318/0026008.

As part of the project, a selection procedure was carried out for suppliers of modifications, technologies and devices in accordance with the rules of OP PIK. In the first stage, modifications were partially implemented in the technologies of the production premises and the first part of the technologies for the Brno facility was purchased. For facilities required by legislation, IQ and OQ level qualifications were carried out at the end of the first stage.

The goal of the project is the creation of a new production and control center of AUMED, a.s., which will use the results of its own R&D for the production of an innovative product based on transfer factor (TFI). The project is provided with financial support from the EU within the Operational Program Entrepreneurship and Innovation for Competitiveness, Innovation Challenges – Innovation Project – Challenge VIII.